Stasko Andrew J, Stammers Alfred H, Mongero Linda B, Tesdahl Eric A, Weinstein Samuel
SpecialtyCare, Inc., Nashville, Tennessee.
J Extra Corpor Technol. 2017 Dec;49(4):241-248.
Utilization of intraoperative autotransfusion (IAT) during cardiac surgery with cardiopulmonary bypass (CPB) has been shown to reduce allogeneic red blood cell transfusion. Previous research has emphasized the benefits of using IAT in the intraoperative period. The present study was designed to evaluate the effects of using IAT on overall hematocrit (Hct) drift between initiation of CPB and the immediate postoperative period. We reviewed 3,225 adult cardiac procedures occurring between February 2016 and January 2017 at 84 hospitals throughout the United States. Data were collected prospectively from adult patients undergoing cardiac surgery with CPB, and stored in the SpecialtyCare Operative Procedural rEgistry (SCOPE), a large quality improvement database. Patients receiving allogeneic transfusion and those with missing covariate data were excluded from analysis. The effect of IAT volume returned to patients on the primary endpoint, hematocrit change from CPB initiation to intensive care unit (ICU) entry, was assessed using a multivariable linear mixed effects regression model controlling for patient demographics, operative characteristics, surgeon, and hospital. Descriptive analysis showed greater positive hematocrit change with increasing autotransfusate volume returned. Those patients with no IAT volume returned saw a median hematocrit change of +2.00%, whereas those with more than 380 mL/m BSA had a median Hct drift of +5.00% ( < .001). After controlling for known confounds, our regression estimate of the effect of IAT volume returned on Hct drift was +.0045% per 1 mL/m BSA ( < .001). For a patient with the median autotransfusate volume returned (273 mL/m BSA), and all other covariate values at their respective medians, this translates to a predicted hematocrit change of +3.6% (95% CI +3.1 to +4.1). These findings lend further support to the notion that autotransfusate volume is positively associated with increases in postoperative hematocrit.
在体外循环(CPB)心脏手术期间使用术中自体输血(IAT)已被证明可减少异体红细胞输血。先前的研究强调了在手术期间使用IAT的益处。本研究旨在评估使用IAT对CPB开始至术后即刻期间总体血细胞比容(Hct)漂移的影响。我们回顾了2016年2月至2017年1月期间在美国84家医院进行的3225例成人心脏手术。数据是前瞻性收集自接受CPB心脏手术的成年患者,并存储在专业护理手术程序注册库(SCOPE)中,这是一个大型质量改进数据库。接受异体输血的患者和协变量数据缺失的患者被排除在分析之外。使用多变量线性混合效应回归模型评估回输给患者的IAT量对主要终点(从CPB开始到重症监护病房(ICU)入院时的血细胞比容变化)的影响,该模型控制了患者人口统计学、手术特征、外科医生和医院等因素。描述性分析显示,随着回输自体输血量的增加,血细胞比容的正向变化更大。那些没有回输IAT量的患者血细胞比容变化中位数为+2.00%,而那些回输量超过380 mL/m²体表面积的患者血细胞比容漂移中位数为+5.00%(P<0.001)。在控制了已知的混杂因素后,我们对回输IAT量对Hct漂移影响的回归估计为每1 mL/m²体表面积增加+.0045%(P< 0.001)。对于回输自体输血量中位数(273 mL/m²体表面积)且所有其他协变量值处于各自中位数的患者,这转化为预测的血细胞比容变化为+3.6%(95%可信区间为+3.1至+4.1)。这些发现进一步支持了自体输血量与术后血细胞比容增加呈正相关的观点。